|
助理教授，特聘研究员，博士生导师。 研究方向：（1）基于疾病代谢特点精准干预策略开发；（2）生物纳米药物研发；（3）核酸药物设计与递送。 研究成果：以第一作者/通讯作者在Nature Nanotechnology，Journal of Nanobiotechnology，Biomaterials等SCI期刊上发表多篇论文。主持国家级、省部级、校级项目等5项。 化学、药学、生物学等多学科交叉课题组，欢迎各专业研究生与本科生的加入 中国药学会 会员 iScience等期刊审稿专家 1. Yue C#, Lu W#, Fan S#, Huang Z, Yang J, Dong H, Lai W, Li D, Dong T, Yuan A, Wu J, Kang L, Hu Y*. Nanoparticles for Inducing Gaucher Disease-like damage in cancer cells. Nature Nanotechnology. 2024 Aug;19(8):1203-1215. 2. Wang X#, Zhang T#, Wang S, Shi H, Dong H, Huang Y, Lai W*, Hu Y*, Yue C*. Bio-nanocomplexes impair iron homeostasis to induce non-canonical ferroptosis in cancer cells. Journal of Nanobiotechnology. 2025, 23: 121. 3. Yue C#, Li D#, Fan S, Tao F, Yu Y, Lu W, Chen Q, Yuan A, Wu J, Zhao G, Dong H*, Hu Y*. Long-term and liver-selected ginsenoside C–K nanoparticles retard NAFLD progression by restoring lipid homeostasis. Biomaterials. 2023 Oct:301, 122291. 4. Wang R#, Yue C#, Cong F, Lou Y, Liu Y, Xu C, Li X*, Huang Y*. A sustained-release gel alleviates neuropathic pain in SNI mice by reversing Glu/GABA imbalance and chloride efflux disorders. Int J Biol Macromol. 2025, 286:138501. 5. Wang Y#, Yue C#, Zhang M, Li D, Xu T, He Meng, Wang M, Zhao Y, Ni Z, Zhi F, Hu Y*, Ding D*. Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment. Chemical Engineering Journal. 2023, 452 (1), 139108. 6. Lu W, Li D, Tao F, Chen Q, Fan S, Ma Y, Dong H, Hu Y*, Yue C*. Exploration of NPC2 as a Potential Biomarker for Immunotherapy Using RNA-seq and Protein Data - A New Hypothesis. Endocr Metab Immune Disord Drug Targets. 2023, 23(10):1340-1353. 7. Huang Y#, Wang J#, Yue C#, Wang R, Guo Q, Wang T, Wang D, Dong H, Hu Y*, Tao G*, Li X*. An In Situ Assembled Trapping Gel Repairs Spinal Cord Injury by Capturing Glutamate and Free Calcium Ions. Small. 2023 Apr;19(16): e2206229. 8. Tan Z#, Yue C#, Ji S, Zhao C, Jia R, Zhang Y, Liu R, Li D, Yu Q, Li P, Hu Z, Yang Y, Xu J*. Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies. Oncologist. 2021 Dec;26(12): e2227-e2238. 9. Yue C#, Jiang Y#, Li P, Wang Y, Xue J, Li N, Li D, Wang R, Dang Y, Hu Z*, Yang Y*, Xu J*. Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy. Oncoimmunology. 2018 Mar 6;7(7):e1438111. 1. 国家自然科学基金青年基金项目，2023-2025，主持 2. 中央高校基本科研业务费，2024-2026，主持 3. 长三角科技创新共同体联合攻关项目，2024-2027，参与 |
